Convalescent plasma for hospitalized patients with COVID-19 and the effect of plasma antibodies: a randomized controlled, open-label trial

MLA

Guillaume Beaudoin-Bussière, et al. Convalescent Plasma for Hospitalized Patients with COVID-19 and the Effect of Plasma Antibodies: A Randomized Controlled, Open-Label Trial. July 2021. EBSCOhost, https://doi.org/10.1101/2021.06.29.21259427.

APA

Guillaume Beaudoin-Bussière, Nick Daneman, Kent Cadogan Lofstgard, Damon C. Scales, Ryan Zarychanski, Na Li, Renée Bazin, Caroline Gabe, Yang Liu, Jeannot Dumaresq, Philippe Bégin, Lisa Schwartz, Richard Carl, Nadine Shehata, Nancy M. Heddle, Marshall J. Glesby, Alexis F. Turgeon, Heidi Wood, Bruce S. Sachais, … Allison McGeer. (2021). Convalescent plasma for hospitalized patients with COVID-19 and the effect of plasma antibodies: a randomized controlled, open-label trial. https://doi.org/10.1101/2021.06.29.21259427

Chicago

Guillaume Beaudoin-Bussière, Nick Daneman, Kent Cadogan Lofstgard, Damon C. Scales, Ryan Zarychanski, Na Li, Renée Bazin, et al. 2021. “Convalescent Plasma for Hospitalized Patients with COVID-19 and the Effect of Plasma Antibodies: A Randomized Controlled, Open-Label Trial,” July. doi:10.1101/2021.06.29.21259427.